Approval for German Medical Device in China
The GILUPI CellCollector® - the first medical device for in vivo CTC isolation, manufactured by GILUPI - has been approv…
The GILUPI CellCollector® - the first medical device for in vivo CTC isolation, manufactured by GILUPI - has been approv…
Der GILUPI CellCollector® - das erste zugelassene Medizinprodukt zur in vivo – Isolation von zirkulierenden Tumorzellen…
Die Investoren AURELIA, High-Tech Gründerfonds (HTGF), KfW, ILB, der Risikokapitalfonds der Sparkassen des Landes Brande…
The investors AURELIA, High-Tech Gründerfonds (HTGF), KfW, ILB, the - venture capital fund of the Sparkassen of Brandenb…
After the 68th AACC Annual Scientific Meeting & Clinical Lab Expo (AACC), GILUPI GmbH announces that it has received EN…